Join the #BlueBalloonChallenge
Blue Balloon Campaign
Living with type 1 diabetes is like doing everything you do in your daily life, while keeping a balloon in the air. It's a constant balancing act.
This year, we are thrilled to collaborate with Breakthrough T1D, previously JDRF, to illuminate the unsung heroes around us. They are the ones who provide support, who step in to help keep the Blue Balloon floating when doctors and nurses aren't around. They are the partners, the loved ones who make the burden of diabetes a shared load rather than a solitary journey. Help us amplify the story of living with Type 1 diabetes.
Additionally, if you would like to do the #BlueBalloonChallenge in November/ Diabetes Awareness Month, feel free to do so and post it on social media with the #BlueBalloonChallenge hashtag. You could do it with a partner to be in sync with this year's theme.
Together let’s help make the invisible, visible.
It’s called MiniMed™ 780G and it has improved my quality of life tremendously.
Nicole
MiniMed™ 780G system user
Our Therapies
Insulin Pump Therapies
MiniMed 780G™ System
Automated for an easier way to stabilise glucose levels.
Fewer injections vs
- #Multiple Daily Injections (3 bolus and 1 basal insulin per day) requires 28 injections per week vs. one infusion set change every two to three days.
Helps to reach 80% Time in
Multiple Daily Injection Therapies
What is a Smart MDI System?
This first-in-the-world Smart MDI system combines Guardian™ 4
Portfolio
We’ve developed a robust portfolio of life-transforming technologies that leverage data to deliver personalized insights, so you can take on each day with confidence.
Expertise
With our comprehensive, flexible offerings, our empathetic service and support, you can live fully in the moment. We’re working to help you manage your type 1 diabetes, our way.
- Medtronic data on file: MiniMed ™ 780G data uploaded voluntarily by 12.870 users in EMEA to CareLink™ Personal, from 27 August 2020 to 22 July 2021. Mean 80% TIR reached by 1.784 users using MiniMed ™ 780G with recommended settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
- 1.Medtronic data on file: MiniMed ™ 780G data uploaded voluntarily by 12.870 users in EMEA to CareLink™ Personal, from 27 August 2020 to 22 July 2021. Mean 80% TIR reached by 1.784 users using MiniMed ™ 780G with recommended settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
- * Smart CGM predicts future high and low sensor glucose events up to 1 hour in advance and provides access to additional algorithms and insights that can inform users of clinically relevant glucose patterns. Please refer to IFU.
- ** Smart Insulin pen connects to a mobile app to provide dosing calculations, reminders and CGM system integration. Please refer to IFU.